$12M raised across 1 disclosed Convertible deals.
Latest round · Sep 21, 2026 · RSS
| Date | Company | Amount | Round | Sector | Country | Lead investors |
|---|---|---|---|---|---|---|
| Sep 21, 26 | Novadip Biosciences Novadip Biosciences is a Belgian late-stage clinical biotech company specializing in regenerative medicine. They have developed a proprietary platform using adipose-derived stem cells to create tissue for healing bone defects and fractures. This funding will support their pivotal Phase 3 clinical trial for NVD003 and preparation for regulatory submission in the United States. | $12.0M | Convertible | Health | Belgium | New Science Ventures, Fund+, Wallonie Entreprendre+5 |
Verified emails and LinkedIn profiles, filterable by stage, sector and check size.
Filtered to your country and sector. One email per week.